NanoViricides, Inc. (NNVC)
NYSEAMERICAN: NNVC · Real-Time Price · USD
1.280
+0.020 (1.59%)
Oct 2, 2026, 4:00 PM EDT - Market closed
NanoViricides Market Cap
NanoViricides has a market cap or net worth of $32.67 million as of October 2, 2026. Its market cap has increased by 30.17% in one year.
Market Cap
32.67M
Enterprise Value
29.88M
1-Year Change
30.17%
Ranking
Category
Stock Price
$1.28
ChartMarket Cap Chart
Since September 25, 2013, NanoViricides's market cap has decreased from $293.90M to $32.67M, a decrease of -88.88%. That is a compound annual growth rate of -15.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 32.67M | 60.95% |
| Dec 31, 2025 | 20.30M | -0.98% |
| Dec 31, 2024 | 20.50M | 70.83% |
| Dec 29, 2023 | 12.00M | -6.98% |
| Dec 30, 2022 | 12.90M | -69.93% |
| Dec 31, 2021 | 42.90M | 40.20% |
| Dec 31, 2020 | 30.60M | 215.46% |
| Dec 31, 2019 | 9.70M | -30.22% |
| Dec 31, 2018 | 13.90M | -75.04% |
| Dec 29, 2017 | 55.70M | -10.59% |
| Dec 30, 2016 | 62.30M | -8.38% |
| Dec 31, 2015 | 68.00M | -56.21% |
| Dec 31, 2014 | 155.30M | -35.32% |
| Dec 31, 2013 | 240.10M | -18.31% |
| Sep 25, 2013 | 293.90M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CEL-SCI | 36.76M |
| Actinium Pharmaceuticals | 36.16M |
| Aligos Therapeutics | 34.28M |
| Immutep | 33.82M |
| BeyondSpring | 33.46M |
| Quince Therapeutics | 31.20M |
| Seres Therapeutics | 29.13M |
| Context Therapeutics | 28.89M |